Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index; 45 of the 106 sources its claims cite were checked for support.

Epidemiology, genetics, neuroimaging, clinical features, and treatment between overall and performance-only social anxiety disorder: a narrative review

Open access

Abstract

Social anxiety disorder (SAD) is a common psychiatric condition marked by a significant fear of social evaluation. To better identify a meaningful subgroup, the DSM-5 introduced a "performance-only" specifier, replacing the generalised specifier in the DSM-IV. We conducted a narrative review comparing overall SAD (including generalised and performance-only forms) and performance-only SAD across epidemiology, genetics, neuroimaging, clinical characteristics, and treatment... Treatments for overall SAD typically include CBT and pharmacotherapy, such as SSRIs or SNRIs. In contrast, performance-only SAD is...

Overview

CoChat Summary

TL;DR

This narrative review compares overall social anxiety disorder (SAD) with DSM-5 performance-only SAD across epidemiology, genetics, neuroimaging, clinical features, and treatment. It concludes that performance-only SAD may be a distinct subtype with narrower fears, later onset, more male representation, fewer comorbidities, and less impairment, but direct evidence on its genetics, neuroimaging, and treatment remains limited.

Key findings

  • Overall SAD lifetime prevalence is approximately 5–13%, whereas performance-only SAD is approximately 0.3–0.7% and accounts for less than 25% of overall SAD cases when strictly defined by the DSM-5 specifier; broader public-speaking fear estimates range from about 3–5% in community samples.
  • Overall SAD shows familial aggregation, with approximately 25% prevalence among first-degree relatives with SAD versus 5% without such family history, and twin-study heritability estimates of approximately 30–60%; performance-only SAD shows no significant difference by family history of overall SAD, and direct heritability estimates for it are scarce.
  • Overall SAD typically emerges in early adolescence, with about 50% onset by age 13 and 90% by age 23, and is more prevalent in females at approximately 1.5 times the rate in males; performance-only SAD tends to begin in mid-adolescence, is relatively more prevalent among males, and is linked to fewer psychiatric comorbidities, better social functioning, and higher socioeconomic status.
  • Neuroimaging in overall SAD shows fronto-limbic and default mode network alterations, while no structural or fMRI studies have specifically examined performance-only SAD; treatment for overall SAD typically includes CBT and SSRIs/SNRIs, whereas performance-only SAD is commonly managed with exposure-based CBT and sometimes beta-blockers, with limited specific evidence.

Methods

  • Narrative review synthesizing published evidence on overall SAD and performance-only SAD across epidemiology, genetics, neuroimaging, clinical features, and treatment.
  • Literature search used PubMed and Web of Science up to August 2025, with keywords related to social anxiety, performance-only anxiety, public speaking anxiety, and the review domains; reference lists of key articles were manually screened.
  • Included human studies in peer-reviewed journals across epidemiological surveys, family and twin studies, neuroimaging investigations, and clinical trials; findings were organized and narratively synthesized by thematic domain, emphasizing comparisons between overall and performance-only SAD.

Limitations

  • Stated in the paper: direct genetic evidence supporting lower heritability in performance-only SAD is lacking; no neuroimaging studies specifically targeting performance-only SAD have been conducted; hypotheses about lower genetic influence and fewer brain alterations remain speculative; treatment recommendations for performance-only SAD are largely extrapolated from overall SAD; and most genetic studies have analyzed SAD as a single, undifferentiated phenotype.
  • Evident from the review design: as a narrative review, it does not report a systematic search protocol, risk-of-bias assessment, or quantitative synthesis, so findings may be subject to selection and interpretation bias.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1080/19585969.2026.2661986

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. Changes in the specifiers of social anxiety disorder in the DSM-IV and DSM-5: From generalised and nongeneralized to performance-only.
Figure 1. Changes in the specifiers of social anxiety disorder in the DSM-IV and DSM-5: From generalised and nongeneralized to performance-only.CC BY · PubMed Central

Verification

Claims the paper makes

38 Valid · 16 Not valid · 23 Not checked · 46 Own results and interpretations

75 more claims · 25 with their cited sources checked

Create a free account to see all 123 claims and to verify the 5 references still open.

See all claims — free account
  • It may state two separate claims as one. 26
  • Probably not a substantial claim. 21
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Citations

Cites

Show all 46 references

Research works printed but not linked: 5

  1. APA. 1980. Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM-III). American Psychiatric Publishing.
  2. APA. 1994. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). American Psychiatric Publishing.
  3. APA. 2013. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). American Psychiatric Publishing.
  4. Clark DM, Wells A. 1995. A cognitive model of social phobia. Social phobia: diagnosis, assessment, and treatment. The Guilford Press.
  5. Rose GM, Tadi P. 2024. Social Anxiety Disorder StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Prasanna Tadi declares no relevant financial relationships with ineligible companies. StatPearls Publishing.

Metadata

Authors
Okamura, L., Ueji, Y., Izumi, T., Fujikane, D., Ukisu, T., Murakami, H., Shioiri, T., & Ohi, K.
Affiliations
Gifu University (JP)
Corresponding author
Ohi, Kazutaka
Venue
Dialogues in clinical neuroscience
Published
2026-04-28
Volume
28
Issue
1
Pages
187-195
ISSN
  • 1294-8322 (ISSN-L)
  • 1958-5969
OpenAlex
W7157882315
Cited by
0
References
46
FWCI
0.00
Type
journal article
Language
en
Open access
Locations
  • Dialogues in Clinical Neuroscience (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Japan Society for the Promotion of Science (22K07614, 25K10832, 25K10808)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
  • Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
Keywords
social anxiety disorder, epidemiology, heritability, familial aggregation, neuroimaging, default mode network, fronto-limbic network, clinical features, comorbidities, cognitive behavioral therapy, pharmacotherapy, beta-blockers, exposure therapy, anxiety subtypes
MeSH terms
Phobia, Social, Female, Humans, Male, Neuroimaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Epidemiology, genetics, neuroimaging, clinical features, and treatment between overall and performance-only social anxiety disorder: a narrative review. https://app.cochat.ai/papers/10.1080/19585969.2026.2661986
The paper
Okamura, L., Ueji, Y., Izumi, T., Fujikane, D., Ukisu, T., Murakami, H., Shioiri, T., & Ohi, K. (2026). Epidemiology, genetics, neuroimaging, clinical features, and treatment between overall and performance-only social anxiety disorder: a narrative review. Dialogues in clinical neuroscience. https://doi.org/10.1080/19585969.2026.2661986

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.